SteelSky Ventures focuses on health and healthcare, with a particular emphasis on women's health. The firm's strategy is to invest in early and growth-stage companies that are reshaping care delivery, improving access, and driving better outcomes for women and families, often leveraging AI-driven advancements in areas like digital health, medical devices, and new care delivery models.
57% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Their most common stage is series-a (43% of deals). Average disclosed round size is $35.8M (across 6 rounds with reported amounts).
Portfolio
7
Fund Size
$73M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 myLaurel | Unknown | — | Nov 2025 |
 Commons Clinic | Series B | $26M | Jun 2025 |
| MMotivo Health | Series A | $14M | Aug 2022 |
| CConcertoCare | Series B | $105M | Feb 2022 |
 prooV | Series A | $9.7M | Dec 2021 |
 Raydiant Oximetry, Inc. | Series A | $5M | Nov 2021 |
 Lark Health | Series C | $55M | Oct 2020 |
Top Co-Investors
Deerfield2 shared
RA Capital Management1 shared
Floating Point1 shared
Time BioVentures1 shared
Courtside Ventures1 shared
Wells Fargo1 shared
Obvious Ventures1 shared
Avestria1 shared
Band of Angels1 shared
Lightspeed Venture Partners1 shared
King River Capital1 shared
Franklin Templeton1 shared
Olive Tree Ventures1 shared
Marvell Technology1 shared
GingerBread Capital1 shared
Cox Enterprises1 shared
Great Oaks1 shared
GV (Google Ventures)1 shared
Last updated: 8 March 2026